31.01.2017
- US company Barr Laboratories, a subsidiary of Israeli drugmaker Teva, has reached a $225 million settlement in an antitrust class action that accused Teva of keeping a generic...
02.10.2012
- U.S. antitrust regulators found no wrongdoing in a deal made four years ago between German drugmaker Bayer and a division of Teva Pharmaceuticals to end patent litigation over the...
29.10.2010
- Teva Pharmaceutical Industries will buy Merck KGaA's women's health unit Theramex for €265 million ($367.8 million) to strengthen its women's health franchise outside the United...
